|
"hsu ta"的相關文件
顯示項目 36-45 / 92 (共10頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2014-11 |
Discovery of multiple kinases inhibitors, DBPR114, as the novel anti-cancer agent
|
Hsieh, HP;Kuo, CC;Chiu, JJ;Hsu, TA;Yeh, TK;Chen, CT |
| 國家衛生研究院 |
2014-10-29 |
作為極光激酶抑制劑的稠合雙環嘧啶化合物
|
Hsieh, HP;Coumar, MS;Hsu, TA;Wu, SY;Chao, YS |
| 國家衛生研究院 |
2014-10-21 |
化合物於製造治療病毒感染的藥物之用途
|
Hsieh, HP;Hsu, TA;Yeh, JY;Horng, JT;Shih, SR;Chang, SY;Chao, YS |
| 國家衛生研究院 |
2014-10 |
Novel irreversible EGFR tyrosine kinase inhibitor, DBPR112, as a therapeutic candidate for lung adenocarcinoma
|
Shiao, HY;Hsu, TA;Lin, WH;Yang, TT;Hsieh, HF;Chen, CT;Yeh, TK;Hsieh, HP |
| 國家衛生研究院 |
2014-04-29 |
Quinoline compounds and their use for treating viral infection
|
Hsieh, HP;Hsu, TA;Yeh, JY;Chao, YS |
| 國家衛生研究院 |
2014-04-21 |
作為蛋白質激酶抑制劑之吡唑化合物及噻唑化合物、其醫藥組成物及用途
|
Jiaang, WT;Hsu, TA;Lin, WH;Chao, YS |
| 國家衛生研究院 |
2014-03-20 |
Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
|
Hsieh, HP;Coumar, MS;Hsu, TA;Wu, SY;Chao, YS |
| 國家衛生研究院 |
2013-10-01 |
喹啉化合物及包含其之治療病毒感染之醫藥組成物
|
Hsieh, HP;Hsu, TA;Yeh, JY;Chao, YS |
| 國家衛生研究院 |
2013-08-13 |
Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors
|
Hsieh, HP;Coumar, SM;Hsu, TA;Lin, WH;Chen, YR;Chao, YS |
| 國家衛生研究院 |
2013-06 |
Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities
|
Lin, CH;Chang, TC;Das, A;Fang, MY;Hung, HC;Hsu, KC;Yang, JM;Von Itzstein, M;Mong, KKT;Hsu, TA;Lin, CC |
顯示項目 36-45 / 92 (共10頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
